Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Management of disease modifying treatments in neurological autoimmune diseases of the central nervous system.
Reduced Myelin Water in the White Matter Tracts of Patients with Niemann-Pick Disease Type C.
Nutrition and Lifestyle Intervention on Mood and Neurological Disorders.
Histone deacetylase gene variants predict brain volume changes in multiple sclerosis.
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.
Tried-and-True Antibiotic May Block Conversion to MS
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.
Inadvertent foley catheterization of the ureter.
Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort.
Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.
Integrin-based therapeutics: biological basis, clinical use and new drugs.
Aging-associated changes in motor axon voltage-gated Na(+) channel function in mice.
Prognostic Factors of MS Conversion in Optic Neuritis.
Identification of tissue-specific cell death using methylation patterns of circulating DNA.
Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and th17 T-helper cell subsets and is a direct stat target gene.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Successful treatment for neuromyelitis optica with systemic lupus erythematosus.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
Functional connectivity analyses using emulated and conventional resting state data: Parts vs. the whole story.
Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation.
A concise synthesis of Fingolimod: an orally available drug for treating multiple sclerosis.
Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.
Sex-related differences of cAMP-specific PDE4B3 mRNA in oligodendrocytes following systemic inflammation.
Pages
« first
‹ previous
…
367
368
369
370
371
372
373
374
375
…
next ›
last »